CNCR
ETF Series Solutions Trust Range Cancer Therapeutics ETF
CNCR
CNCR
Delisted
CNCR was delisted on the 27th of May, 2025.
21 hedge funds and large institutions have $8.41M invested in ETF Series Solutions Trust Range Cancer Therapeutics ETF in 2019 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 9 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
60% less capital invested
Capital invested by funds: $20.9M → $8.41M (-$12.5M)
Holders
21
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$2.76M | |
| 2 | +$712K | |
| 3 | +$104K | |
| 4 |
BWA
BDO Wealth Advisors
Jacksonville,
Florida
|
+$72K |
| 5 |
RFWA
RPg Family Wealth Advisory
Burlington,
Massachusetts
|
+$26.3K |
Top Sellers
| 1 | -$921K | |
| 2 | -$761K | |
| 3 | -$752K | |
| 4 |
Jane Street
New York
|
-$567K |
| 5 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
-$194K |